Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC | News
Search Refinements

OTC News

View news from other Pharmaceutical sectors:
136-150 of 1692 results
Perrigo to promote Paragon BioTeck's ilast products in US
By PBR Staff Writer
US-based Paragon BioTeck has entered into a multi-year agreement with Irish healthcare supplier Perrigo Company to promote the ilast range of products for eyelid hygiene in the US.
Production & Manufacturing > OTC > News
Axxess Pharma's Tapout products now available in 300 plus fitness centers across North America
By PBR Staff Writer
Canada-based Axxess Pharma through its subsidiary AllStar Health Brands USA has signed a contract with AVT, a North American builder and provider of vending machines.
Production & Manufacturing > OTC > News
Perrigo takes over Mexican operations of Patheon for $34m
By PBR Staff Writer
Irish over-the-counter (OTC) firm Perrigo has acquired the Mexican operations of US-based contract pharmaceutical services company Patheon for $34m.
Production & Manufacturing > OTC > News
SeabuckWonders unveils new Hair, Skin & Nails supplement in US
By PBR Staff Writer
US-based SeabuckWonders has launched its new Ultimate Hair, Skin & Nails supplement, which is the only product to feature both Biotin and Sea Buckthorn Oil with rare Omega-7 for US consumers.
Production & Manufacturing > OTC > News
Horizon Pharma enters into settlement and license agreement with Perrigo for Pennsaid 2% patent litigation
Horizon Pharma, a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced that its affiliates have entered into a settlement and license agreement with Perrigo Company and its subsidiary Paddock Laboratories, collectively (Perrigo), to resolve pending patent litigation involving Pennsaid (diclofenac sodium topical solution) 2% w/w (Pennsaid 2%).
Production & Manufacturing > OTC > News
Actavis to re-launch generic pulmicort Respules after favorable appeals court ruling
Actavis has announced that it will immediately re-launch its generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) 0.25 and 0.5mg vials following a decision from the United States Court of Appeals for the Federal Circuit to uphold a lower court's ruling that United States Patent No. 7,524,834 is invalid.
Production & Manufacturing > OTC > News
Lipocine completes Phase III trial of oral testosterone LPCN 1021
Lipocine(LPCN), a specialty pharmaceutical company, has announced the completion of the last patient visit in the safety assessment portion of its Study of Oral Androgen Replacement (SOAR) pivotal Phase III clinical study evaluating efficacy and safety of LPCN 1021, an Oral Testosterone product, in hypogonadal men with low testosterone (Low T).
Production & Manufacturing > OTC > News
Nutra Pharma's OTC drug Nyloxin gets acceptance from CPAM
Nutra Pharma, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, has received notification of the acceptance of Nyloxin by the China International Exchange and Promotive Association for Medical and Healthcare (CPAM).
Production & Manufacturing > OTC > News
Irish OTC firm Perrigo rejects Mylan's raised bid
By PBR Staff Writer
Irish over-the-counter (OTC) firm Perrigo has rejected the revised unsolicited offer from Mylan to acquire all of the outstanding shares of Perrigo for $75 per share in cash and 2.3 Mylan shares for each Perrigo share.
Production & Manufacturing > OTC > News
Axxess gets Nutrition House approval to expand full tapout line across Canada
By PBR Staff Writer
Axxess Pharma has received approval from Nutrition House, Canada's leading health product franchise, to sell its full line of Tapout products at more than 60 high profile shopping centers across Canada from early summer.
Production & Manufacturing > OTC > News
Easton Pharmaceuticals launches first three OTC products
Easton Pharmaceuticals has successfully launched its first 3 OTC Products at the recently attended Total Health Show and Yoga Show, proceeds towards completion of its 2014 year end audit.
Production & Manufacturing > OTC > News
Health Canada grants approval for Pivotal to expand Omazen indication
By PBR Staff Writer
Pivotal Therapeutics has received approval from Health Canada to expand the indication of Omazen's product line specifically for cardiovascular health.
Production & Manufacturing > OTC > News
Moberg Pharma acquires OTC brand Balmex from Chattem
By PBR Staff Writer
Swedish pharmaceutical firm Moberg Pharma has acquired Balmex, an over-the-counter (OTC) brand in the US from Sanofi's US Consumer Healthcare Division, Chattem, for $3.9m.
Production & Manufacturing > OTC > News
Axxess signs manufacturing, marketing and distribution deal with Tong
By PBR Staff Writer
Axxess Pharma, a US-based provider of nutritional supplements and over-the-counter (OTC) remedies, has signed a long-term manufacturing, marketing and distribution agreement with 8E6Tong Private Company (Tong), a Singapore-registered company.
Production & Manufacturing > OTC > News
Actavis introduces Avycaz in US to treat cIAI and cUTI
By PBR Staff Writer
Irish pharmaceutical firm Actavis has launched Avycaz (ceftazidime-avibactam) in the US to treat adult patients with complicated intra-abdominal infections (cIAI) (in combination with metronidazole).
Production & Manufacturing > OTC > News
136-150 of 1692 results